Awarded to
Alliance Healthcare s.r.o.; GlaxoSmithKline, s.r.o.; ELI LILLY ČR, s.r.o.
- Awarded value
- €5,688,408 4% under the estimate of €5,921,945
- Award date
- Record with this buyer
- 1 first contract from this buyer in the register
- Back on the market
- Jun 2029 How we know
When this contract comes back
This contract runs about 48 months, so it is back on the market around June 2029.
Every contract expiring, on the radarDescription
Official source
Source: TED - Tenders Electronic Daily (Publications Office of the EU)
Always verify details on the official notice.
Report an error in this notice
Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 1 week ago
What this buyer has paid before
Based on 242 comparable contracts this buyer awarded in this sector over the last 4 years.
- This award
- €5.7M
- Estimated value
- €5.9M
- Median award
- €290,988
- Middle half of past awards
- €105,115 to €1.0M
The award is larger than three in four past awards.
Most recent awards
- Česko - Náhrady plazmy a perfúzní roztoky - Roztoky a spotřební materiál pro hemofiltraci €2,774,249
- Czech Republic - Operating theatre equipment - ENT operating microscope including post-warranty services €372,264
- Česko - Léčivé přípravky pro štítnou žlázu - Léčivé přípravky s obsahem sodné soli levothyroxinu - VEŘEJNÁ LÉKÁRNA II €86,247
- Česko - Gynekologika, antiinfektiva a antiseptika - Léčivé přípravky s obsahem solifenacinu €13,011
- Česko - Náhrady plazmy a perfúzní roztoky - Léčivé přípravky s obsahem elektrolytů a jejich kombinace €292,905
Award values as published by the official sources. Use them as a guide, not a rule: scope, lots and duration differ between contracts.
The buyer
Full buyer profileFakultní nemocnice Hradec Králové
- notices in the register
- 972
- awards
- 502
- awarded in total
- €414.9M
Who wins its contracts
Many suppliers- different companies won its awards
- 201
- of the awards went to the three most frequent winners
- 26%
- of its calls state an estimated value
- 90%
Based on 429 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.
Competition
- tenders per lot on average (open and restricted procedures)
- 1.8
- of those lots received a single tender
- 49%
- of the awards went to companies based in another country
- 1%
As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.
One dot per award, on the day it was signed, sized by its value. A ring is an award with no published value.
Awards most often to
35 open tenders right now
Market context
- open now in Medical equipment & pharmaceuticals
- 8,192
- median open notice
- €303,562
Who wins in this market
Many suppliersCzechia · Medical equipment & pharmaceuticals
- different companies won awards here
- 1,137
- of the awards went to the three most frequent winners
- 19%
- buyers awarded contracts here
- 173
Based on 4,860 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.
Competition
- tenders per lot on average (open and restricted procedures)
- 1.6
- of those lots received a single tender
- 61%
- of the awards went to companies based in another country
- 1%
- of the tenders came from another country
- 1%
As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.
Similar tenders
Open now
31
days left
€7,640,650
est. value
1
day left
Czech Republic - Antineoplastics - Oral cytostatic drug containing the active substance Belzutifanum
€2,072,613
est. value
2
days left
€10,204,899
est. value
11
days left
€2,489,561
est. value
31
days left
€2,062,237
est. value
Awarded before
Never miss a tender like this
201 new notices in Medical equipment & pharmaceuticals in Czechia in the last 7 days. Get an email when new ones appear. Free.
Set up my alertOr follow just its CPV code, Antineoplastic agents: an email when new tenders arrive under it, no account needed.